{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:50:23Z","timestamp":1758441023873,"version":"3.44.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.mayocp.2020.01.005","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T08:08:12Z","timestamp":1585728492000},"page":"828-829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increasing Resistance to Third-Generation Cephalosporins in Spontaneous Bacterial Peritonitis"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8415-7934","authenticated-orcid":false,"given":"Nishant","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niki","family":"Koirala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.mayocp.2020.01.005_bib1","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.mayocp.2018.12.036","article-title":"Prevalence and predictors of third-generation cephalosporin resistance in the empirical treatment of spontaneous bacterial peritonitis","volume":"94","author":"Sunjaya","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.mayocp.2020.01.005_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/eci.12701","article-title":"Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis","volume":"47","author":"Lutz","year":"2017","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"10.1016\/j.mayocp.2020.01.005_bib3","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s10620-019-05519-4","article-title":"Evidence of significant ceftriaxone and quinolone resistance in cirrhotics with spontaneous bacterial peritonitis","volume":"64","author":"Ardolino","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.mayocp.2020.01.005_bib4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/jgh.13266","article-title":"Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis","volume":"31","author":"Friedrich","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.mayocp.2020.01.005_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12879-018-3101-1","article-title":"Clinical and bacteriological features and prognosis of ascitic fluid infection in Chinese patients with cirrhosis","volume":"18","author":"Ning","year":"2018","journal-title":"BMC Infect Dis"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962030032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962030032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:33:15Z","timestamp":1758418395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561962030032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S002561962030032X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.01.005","relation":{},"ISSN":["0025-6196"],"issn-type":[{"type":"print","value":"0025-6196"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing Resistance to Third-Generation Cephalosporins in Spontaneous Bacterial Peritonitis","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.01.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.12.036","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}